uOmnispace.MR

uOmnispace.MR is an advanced medical image post-processing software designed to enhance diagnostic capabilities by providing a comprehensive suite of tools for viewing, manipulating, and quantitatively analyzing MR images across various anatomical regions and physiological functions. Its methodology incorporates sophisticated algorithms, including AI-driven segmentation for cardiac analysis and specialized modules for spectroscopy, perfusion, and dynamic studies, validated to ensure accurate and reliable image evaluation for clinical interpretation.

uOmnispace.MR is a comprehensive medical image post-processing software designed for viewing, manipulating, evaluating, and analyzing Magnetic Resonance (MR) images within healthcare settings. It operates on the uOmnispace platform and can function independently or with other cleared applications, supporting interpretation and evaluation of examinations. The software includes a suite of specialized tools tailored for diverse clinical needs: Stitching for creating full-format images from overlapping MR volumes; Dynamic for general time-course study post-processing; MRS (MR Spectroscopy) for evaluating molecular constitution and spatial distribution of cell metabolism using SVS and CSI data; MAPs for applying arithmetic and statistical functions to grayscale values for evaluating dynamic processes; Breast Evaluation for calculating parameter maps from contrast-enhanced time-course images; Brain Perfusion for visualizing temporal variations in dynamic susceptibility time series; Vessel Analysis for MR vascular image assessment; DCE analysis for dynamic contrast-enhanced MRI evaluation; United Neuro for neurological image analysis; Cardiac Function for functional analysis of cardiac MR images; and Flow Analysis for evaluating flow in MR images. The uOmnispace.MR's methodology relies on advanced image processing algorithms, including but not limited to motion correction, series registration, parametric mapping (such as T1rho and Signal Enhancement Ratio), and segmentation techniques, specific to each of its applications. A key scientific component is the MR Cardiac Function module, which incorporates a deep learning-based AI algorithm for automatic left and right ventricular contour segmentation. Performance results from software verification and validation testing demonstrated the device's safety and efficacy. Specifically, new parameters and algorithms such as SER in MR Breast Evaluation, T1rho in MR MAPs, and semi-automatic contour segmentation with additional output parameters (mean pressure gradient, peak pressure gradient) in MR Flow Analysis were successfully validated. The AI-driven ventricular segmentation algorithm underwent rigorous evaluation using 114 diverse patient datasets, achieving a Dice coefficient of 1.00 when compared to a predicate device, indicating high consistency and accuracy. This validation was supported by ground truth annotations from experienced cardiologists and confirmed the independence of training and testing data.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the deep learning-based automatic ventricular segmentation algorithm in uOmnispace.MR Cardiac Function compare to manual segmentation by expert clinicians in terms of accuracy and time-efficiency across various pathologies and image qualities?; What specific image processing techniques are employed by the uOmnispace.MR MAPs application for T1rho calculation, and how do these results correlate with histological findings or other quantitative MRI biomarkers?; Can the uOmnispace.MR Brain Perfusion application differentiate between different causes of perfusion abnormalities (e.g., stroke, tumor, inflammation), and what is its sensitivity and specificity for detecting subtle perfusion changes?; For the uOmnispace.MR MRS module, what is the range of detectable metabolites, and how does the software handle potential artifacts or signal-to-noise limitations in SVS and CSI data acquisition from different MR scanner vendors?; Considering the addition of semi-automatic contour segmentation and new pressure gradient parameters in MR Flow Analysis, what is the demonstrated impact on inter-observer and intra-observer variability in quantitative flow measurements?